08/16/2021 8:12 PM
Clarín.com
Society
Updated 08/16/2021 8:12 PM
Pfizer and BioNTech presented the preliminary results of their clinical trials to the US authorities to ask for
approval of a booster dose of
the coronavirus vaccine to
all those over 16 years of age
.
So far, the Food and Drug Administration (FDA) has authorized the third dose of Pfizer and Moderna
only for people with a weakened immune system
, as they have not responded like the general population to vaccines, which It is calculated that it represents 3% of the country's population.
According to data provided by Pfizer on Monday, the booster dose generated "
significantly higher
neutralizing antibodies
" against the original strain of the coronavirus, in addition to the Beta and Delta variants, the company said in a statement.
Participants in the clinical trial received a third dose
eight to nine months after the second
, the text specified.
"The data we have seen so far suggests that a third dose of our vaccine elicits antibody levels that
significantly exceed those of the initial two doses
," Pfizer CEO Albert Bourla said in the statement.
Pfizer CEO Albert Bourla.
stated that the levels of antibodies with the third dose far exceed those of the first two.
Photo: AFP
Pfizer further revealed that it expects to receive results from the final phases of the booster dose clinical trials shortly, which it will also present to the FDA and regulatory authorities around the world.
The data is released three days after the US authorized the administration of the third dose for people with a weakened immune system, such as organ transplant patients, people with HIV or some cancer patients, who did not register an immune response adequate to the first two vaccines.
At the moment, health authorities are not recommending a booster dose for the general population, but the US government's top epidemiologist, Anthony Fauci, recently stated that it
"probably" will be necessary at some point
.
Source: EFE
DD
Look also
Coronavirus: An Argentine "booster" vaccine could start phase 1 trials in early 2022
Scandal in Salta: three arrested for falsifying recipes to vaccinate adolescents against the coronavirus
Why Uruguay began to apply a third booster dose against the coronavirus
